Status:
COMPLETED
Assess Cancer in Ovarian Tumors With Biomarkers.
Lead Sponsor:
Ciphergen Biosystems
Conditions:
Ovarian Tumor
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Purpose The OvaRI assay clinical trial is directed at evaluating a novel proteomics-based blood test. This test is for a physician to use towards differentiating benign from malignant ovarian tumors ...
Detailed Description
Study Design This is a multi-center study including low and high prevalence ovarian cancer sites. The sites are representative of all institutions where potential ovarian tumor subjects will undergo a...
Eligibility Criteria
Inclusion
- Subject is female and age 18 years or older
- Subject has a level of understanding sufficient to agree to all tests required by the protocol, must be considered reliable and must be able to cooperate with study procedures
- Subject signs approved written informed consent prior to any study procedures being performed
- Subject must agree to venipuncture
- Subject has a documented adnexal tumor with planned surgical intervention
Exclusion
- Women under age 18
- No planned surgical intervention
- Decline phlebotomy
- Diagnosis of malignancy in the last 10 years, with the exception of a non-melanoma skin cancer
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2008
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00436189
Start Date
February 1 2007
End Date
April 1 2008
Last Update
April 30 2008
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Consultants
Hoover, Alabama, United States, 35216
2
Women's Health Research
Phoenix, Arizona, United States, 85015
3
Precision Trials
Phoenix, Arizona, United States, 85032
4
Gynecologic Oncology Associates
Newport Beach, California, United States, 92663